The prevalence of asthma has been rising in recent decades. It is the most common disease among pregnant women and affects ca. 12% of this population. The course of asthma in pregnancy may change. In 1/3 of patients, it worsens; in 1/3 of patients, the symptoms are milder; in 1/3 of patients, it remains unchanged. Well-controlled asthma decreases the risk of pregnancy complications. Uncontrolled and severe asthma increases the risk of congenital malformations and obstetrical complications for both mother and baby. Exacerbations may also contribute to poor pregnancy outcomes. These occur mostly either in the first or in the second trimester. The most common triggers are viral infections and treatment non-compliance. The key to maintaining and gaining control of asthma is active treatment of asthma and its exacerbations.
IntRoduCtIon
The prevalence of allergic diseases and asthma has been rising in recent decades, reaching 5% of the adult, and 10% of the child and teenage population in Poland. Asthma is the most common disease complicating pregnancy, which affects 12% of pregnant women [1] , and may lead to poor maternal and neonatal outcomes, especially in severe, uncontrolled, or inappropriately managed cases [2] . Likewise, pregnancy, by leading to multiple changes in the organism, influences the course of asthma. It is believed that the course of asthma during pregnancy improves in approximately one third of patients, in one third the course of the disease remains stable, and in one third it worsens. Worsening usually affects patients with uncontrolled and severe asthma, however it can also occur in patients with well-controlled symptoms [3] . Pregnant women with asthma need multidisciplinary and careful management.
The aim of this study is to summarize current knowledge on the bilateral relationship between asthma and pregnancy, and to sum up any recommendations concerning the management of asthma in pregnancy, as this remains a challenge in many aspects.
the possible influence of physiological pregnancy changes on the course of asthma
Developing pregnancy triggers many adaptive changes in the organism. Changes in the anatomical, hormonal, and immune system are particularly important for the control of asthma.
Anatomical changes in physiological pregnancy include: edema, increased vascularity in the upper respiratory tract, mucosa, and bronchodilation. The diaphragm is displaced, leading to changes in breathing, from a respiratory to abdominal pattern. Tidal volume (TV) and inspiratory capacity (IC) increase, while functional residual capacity (FCR), total lung capacity (TLC) and vital capacity (VC) decrease during the course of pregnancy. Forced expiratory volume in one second (FEV1), peak expiratory flow (PEF) and airway resistance remain unchanged [4, 5] .
Other changes in the respiratory tract include an increase in the respiratory rate and oxygen consumption (for approximately 20%). Eventually, PaO 2 (partial pressure of oxygen) increases to the values 100-105 mm Hg, PCO 2 (partial pressure of carbon dioxide) decreases to the values 27-32 mm Hg. The resulting alkalosis leads to renal loss of bicarbonates and to a decrease of bicarbonates blood concentrations to the values between 18-21mEq/L (Tab. 1). Even a small rise in pCO 2 concentrations (above 35 mm Hg) may indicate respiratory failure and may lead to fetal acidosis. A decrease in PaO 2 concentration below 70 mm Hg, indicates maternal hypoxemia and may also lead to fetal hypoxemia [4, 5] .
Pregnancy leads to intensive hormonal changes. The blood concentration of many hormones rises. A two-fold change is observed in cortisol, a nine-fold change in pro-gesterone, and a 100-1,000 fold in estrogenes serum concentration. The increase in cortisol and progesterone should potentially lead to bronchodilatation; however, due to the competitive affinity of the above-mentioned hormones to the glucocorticoids receptor, the effect may be limited [5, 6] .
Immunological changes in lymphocyte proportions during pregnancy, described as Th 2 domination, may predispose to asthma exacerbations [5, 7] . Moreover, to prevent a maternal response to fetal antigens, the concentration of Th regulatory cells increases. This state results in decreased activation of effector lymphocytes T and natural killers (NK), which, in turn, leads to immunosuppression [7] . This increases susceptibility to viral infections and elevates the risk of possible complications if infection occurs [6] . One of the studies confirmed that the co-existence of asthma and pregnancy may predispose respiratory and urinary tract infections [8] .
the influence of asthma on the course of pregnancy
Correspondingly, asthma may influence the course of pregnancy in numerous ways.
An association between asthma and gestational diabetes, perinatal hemorrhage, placental defects [2] , pre-eclampsia [9] , and congenital defects including cleft palate and gastroschisis [10] , have been confirmed in several meta-analyses. Some studies indicated a risk of cesarean section [2] , preterm birth [11] , low birth weight, longer hospitalization of the newborn and even newborn death [12] . Possible mechanism of mentioned complications include hypoxia, maternal inflammation, changed uterine smooth muscle relaxation, reduction of placental 11 beta hydroxysteroid dehydrogenase enzyme and drug (mainly betamimetics) influence [10, 11] , and is mostly linked with exacerbations [11] . Many authors and guidelines suggest that the complications may be prevented if appropriate effective treatment is used [11, 13] . The latter was confirmed in research from recent years, in which women with diagnosed asthma were enrolled in the programme before 18 week of gestation and obtained active management. This consisted of monthly visits with objective assessment, including spirometry, fractional exhaled nitric oxide (FENO) and the adjustment of medication. A reduction in the prevalence of uncontrolled asthma of 80% was observed. Achieving good asthma control prevented most of the previously mentioned complications. However, the study confirmed that a small, but significantly higher, risk of pre-eclampsia and small for gestational age (SGA) is associated with asthma, despite good control [3] . The risk of SGA increases with increased asthma severity.
diagnostic tests in pregnancy
Proper diagnosis and evaluation of asthma control is crucial, particularly during pregnancy. General approach to asthma diagnose in pregnancy is the same as in non-pregnant patients. Tests generating a risk of pregnancy complications (provocation tests and skin prick tests) are contraindicated during the whole course of pregnancy [4] . Acceptable tests are shown in a Table 2 . Lung function tests are considered to be safe during pregnancy. Interpretation may be difficult, especially during the third trimester of pregnancy [14] , due to associated physiological changes. One recent study demonstrated moderate changes in the pulmonary function. FEV1 declined significantly in second semester (mean 139 mL), then improved significantly in the last weeks of gestation (mean 51 mL higher to baseline). FVC and FEV6 changed insignificantly. Authors suggest that FEV6 may be used in asthma monitoring during pregnancy as it correlated positively with FVC. Nevertheless, changes in pulmonary function were not significantly associated with changes in asthma control [15] . PEF remains a valuable test during pregnancy. It should range between 380-550 L/min, but each asthmatic individual needs to establish his or her best effort. Maintaining levels > 90% of personal best value is considered optimal control [4] . Contraindications • Active asthma treatment outweighs the potential risk of medication use (evidence A)
• Use of available medication to achieve good symptom control and prevent exacerbation is justified, even if the safety is not completely proven (evidence A)
• Cessation of ICS is a risk factor for exacerbations (evidence A)
• Reduction of treatment is not recommended (evidence d)
• Educational resources for patients Step 1 ICs (small dose)* or none
Step 2
ICs (small dose)* or LtRA* or theophylline
Step 3
ICs (small dose) + LAbA* or ICs (medium dose)* or ICs (high dose)* or ICs small dose + LtRA* or ICS small dose + teophylline
Step 4
ICs (medium or high dose) + LAbA* ICs high dose + LtRA* ICS high dose + theophylline add tiotropium
Step 5
Higher lever care* oral glucocorticost eroids* add tiotropium *Emboldened text suggests more suitable therapeutic option in pregnancy for lung function testing include cervix insufficiency and pre-eclampsia [14] . Furthermore, the FENO test was found to be a useful diagnostic tool, and was proven to help in gaining asthma control, if used with monthly control [16] . Moreover, multidisciplinary management [14] and asthma control test were also proven to be useful during pregnancy. The latter test correlates well with actual asthma control.
Asthma treatment in pregnancy, peripartum and lactation Pregnancy
Despite constant concern about medication safety in pregnancy, asthma treatment is generally consid- Mepolizumab -----ISC -inhaled glucocorticosteroids; LABA -long acting betamimetics; LTRA -acting betamimetics sufficient data concerning tiotropium and mepolizumab in pregnancy. Although guidelines on asthma treatment are easily accessible, most studies confirm a tendency to reduce treatment in pregnant women.
Up to 40% of patients declared to give up treatment after getting pregnant without consultation with a doctor [6] . The declarations mentioned may be partly confirmed by a Dutch study using a large database, comprising of detailed data on prescriptions. It shows a clear tendency for a reduction in the number of prescriptions issued after a diagnosis of pregnancy, which may indicate a decline in treatment after getting pregnant. This phenomenon may partly be the result of a milder course of asthma during pregnancy [23] . In addition, the problem of under-treatment is related to medical personnel, as pregnant asthmatics were significantly less likely to be given oral steroids, either in the emergency department or on discharge from hospital, than non-pregnant women [9] , regardless of recommendations and results of studies that concluded on the relative safety of systemic GCS use for asthma exacerbations [12] . In the study cited, the use of systemic GCS was not related to poor perinatal outcomes, except for an increases rate of caesarean delivery.
Proper education on the treatment and safety of both patients and physicians may play an essential role in the improvement of asthma treatment during pregnancy.
Peripartum
Although exacerbations of asthma in peripartum period are rare, regular treatment should be maintained to avoid exacerbations. Hyperventilation [13] and drugs indicated due to obstetric and anesthetic management of labour may influence asthma and cause bronchospasm [24] . Short acting betamimetics are drugs of choice for peripartum bronchospasm [4, 13] . Neonates require blood glucose control for the subsequent 48 hours after exposure to excessive doses of mentioned drugs, to detect possible hypoglycemia [13] . Specification and safety of the most frequently used drugs in peripartum period is enclosed in Table 6 .
Breastfeeding
Although studies concerning safety of anti-asthmatic drugs are limited, most of the drug groups are considered safe in lactation. For inhaled glucocorticosteroids (budesonide, fluticasone) infant exposure is far below the therapeutic level for an infant. Available in vitro studies for ciclesonide predict undetectable exposure of infant [25] . Inhaled betamimetics are accepted during breastfeeding as their concentrations in mothers' blood remain low. [25, 26] . Antileukotrienes, anticholinergic agents and omalizumab are accepted if necessary for asthma control and the excretion into milk or bioavailability (omalizumab) is suggested to be minimal [27] . Among oral glucocorticosteroids prednisolone is preferred to avoid double peak of parent medicine and [25] .
Patophysiological factors influencing the course of asthma during pregnancy Exacerbations
Exacerbations of asthma during pregnancy represent a significant problem that may lead to unfavourable pregnancy outcomes. About 5 to 20% of asthmatic pregnant women require medical intervention due to the occurrence of exacerbations of asthma during pregnancy [9] . It has been suggested that well-controlled asthma, together with no history of previous exacerbations and no prescribed controller medication, is associated with a lower risk of exacerbations during pregnancy [28] ; however, these may occur in up to 37% of pregnancies complicated by well-controlled asthma, and 40% of these exacerbations may be severe [3] .
In most of the studies, exacerbations occurred in the second trimester of pregnancy [9] . However, in one recent study, exacerbations were detected most frequently during the first trimester of pregnancy [3] . Moreover, Blais et al. [29] confirmed the risk of congenital malformation and its association with exacerbations in 19% in of pregnancies during the first trimester. These findings may indicate a need for the intensification of treatment and management of asthma preconceptionally.
The most important trigger of exacerbations are infections, to which pregnant women are more susceptible due to adaptive changes in the immune system. Respiratory tract infections are the most frequent of these [8] . It was also confirmed that both pregnancy and asthma raise the risk of AH1N1 influenza [30] . Furthermore, influenza vaccination in pregnant asthmatics increased the improvement of the condition by 50%, in comparison with 15% in the patients who had not been vaccinated [31] .
Another important factor for exacerbations is lack of treatment compliance [9] . Further factors include inadequate prenatal care, lack of or inappropriate GCS treatment, and smoking [6] .
Some authors consider obesity and excessive weight gain in pregnancy a risk factor for the exacerbation of asthma in pregnancy. Furthermore, an increased risk of gestational diabetes has been noticed in the group of patients with the co-morbidities of asthma and obesity [6] .
The occurrence of severe exacerbations creates a risk of pre-term birth, small for gestational age [6] and pre-eclampsia [3, 6] .
Toxins and allergens exposure
Smoking, both active and passive, is an underestimated factor influencing the course of asthma during pregnancy. About 15% of pregnant women are active smokers [32] ; another 30% are passively exposed to cigarette smoke [33] . Data from the United States shows that from 6 to 30% of pregnancies complicated with asthma are also complicated by active smoking [12] . Another study found more smokers among the group of pregnant women with asthma than among pregnant women without asthma [6] .
Smoking causes many well recognised pregnancy complications [32] (Tab. 7); moreover, in pregnant women with asthma, it increases the risk of severe exacerbation and risk of urinary tract infection and pre-term birth [34] .
A few studies examined the influence of atopy on the course of asthma in pregnancy. The research of Stenius-Aarniala, from 1988, found a more frequent occurrence of exacerbations in non-atopic asthma.
Other factors
Some minor factors may also contribute to a worsening of asthma control during pregnancy or may additionally burden pregnancy.
The influence of psychological stress on the occurrence of exacerbations during pregnancies with asthma has been investigated in many studies. Some of them indicate that anxiety, and a perception by the patient of the asthma as being uncontrolled, may influence exacerbations and be a risk factor for a cesarean section. A more frequent occurrence of depression in pregnancies complicated by asthma exacerbations was confirmed by the Tata research, citated by Murphy [6] .
However, some factors are found to be questionable. No association was found between GERD and asthma severity during pregnancy. A possible reason for this phenomenon may be related to an equal frequency in the presentation of GERD in pregnant and non-pregnant populations [35] .
A few studies have suggested that fetal sex influences the course of asthma during pregnancy, with the course of asthma worsening with a female fetus. However, the data is inconsistent.
Education
Many guidelines point out the importance of education in asthma management and control [13] . This may be even more • sudden infant death syndrome important during pregnancy, as up to 80% of female patients attempting to conceive are concerned about the influence of therapy on the fetus, and up to 40% cease treatment without consultation with a doctor. Pre-conceptional education, with an emphasis on treatment and symptoms of uncontrolled asthma, may play an important role in asthma management [6] . summary Management of asthma during pregnancy remains a challenge in everyday practice. The essentials of good asthma management include proper education and active treatment of patients. Frequent and accurate monitoring is vital to prevent, detect and treat exacerbations, and other conditions influencing the course of asthma. Gaining and maintaining good asthma control may prevent adverse perinatal outcomes for both mother and baby.
